Carboxylic Acid Isostere Derivatives of Hydroxypyridinones as Core Scaffolds for Influenza Endonuclease Inhibitors-Reference-Cited by-同舟云学术

Carboxylic Acid Isostere Derivatives of Hydroxypyridinones as Core Scaffolds for Influenza Endonuclease Inhibitors

Published:2022-12-09 Issue:1 Volume:14 Page:75-82
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Stokes Ryjul W.¹^ORCID,Kohlbrand Alysia J.¹,Seo Hyeonglim¹,Sankaran Banumathi²,Karges Johannes¹^ORCID,Cohen Seth M.¹^ORCID

Affiliation:

1. Department of Chemistry and Biochemistry, University of California, La Jolla, California 92093, United States

2. The Berkeley Center for Structural Biology, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States

Funder

U.S. Department of Health and Human Services

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00434

Reference42 articles.

1. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

2. Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)

3. Immune History and Influenza Vaccine Effectiveness

4. Influenza M2 proton channels

5. Drugs for Influenza Treatment: Is There Significant News?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of 7-membered lactam fused hydroxypyridinones as potent metal binding pharmacophores (MBPs) for inhibiting influenza virus PAN endonuclease;European Journal of Medicinal Chemistry;2024-10

2. Optimization and biological evaluation of l-DOPA derivatives as potent influenza PAN endonuclease inhibitors with multi-site binding characteristics;Bioorganic Chemistry;2024-03

3. Optimization And Biological Evaluation of L-DOPA Derivatives as Potent Influenza PA <sub>N</sub> Endonuclease Inhibitors Withmulti-Site Binding Characteristics;2023